• Updated
  • 0

President Trump announced that his administration is now recommending Americans wear "non-medical cloth" face coverings, but says he won't wear one himself. CNN's Don Lemon says he wishes the president would stop thinking about his own image, and lead by example.

  • Updated
  • 0

BURLINGAME, Calif., April 3, 2020 /PRNewswire/ -- LiveShop Inc., an e-commerce platform to enable local shops to sell easily to their local buyers, has decided to offer their platform to all sellers in the U.S. and U.K.

  • Updated
  • 0

BURLINGAME, Calif., April 3, 2020 /PRNewswire/ -- LiveShop Inc., an e-commerce platform to enable local shops to sell easily to their local buyers, has decided to offer their platform to all sellers in the U.S. and U.K.

  • Updated
  • 0

At the White House coronavirus task force briefing, President Trump berated a reporter after she asked him to clarify comments about the federal medical supply stockpile made by his son-in-law and adviser Jared Kushner the previous day.

  • Updated
  • 0

OAKLAND, Calif., April 3, 2020 /PRNewswire/ -- Kaiser Permanente has announced that it will waive all member out-of-pocket costs for inpatient and outpatient services related to the treatment of COVID-19, as of April 1, 2020. This is intended to alleviate the cost burden and stress on impacted members of paying for care.

  • Updated
  • 0

OAKLAND, Calif., April 3, 2020 /PRNewswire/ -- Kaiser Permanente has announced that it will waive all member out-of-pocket costs for inpatient and outpatient services related to the treatment of COVID-19, as of April 1, 2020. This is intended to alleviate the cost burden and stress on impacted members of paying for care.

  • Updated
  • 0

LOS ANGELES, April 3, 2020 /PRNewswire/ -- In the wake of the current COVID-19 global health crisis, items like medical masks, disinfectants, and hand sanitizers have become scarce. But even after Z Skin Cosmetics had shipped thousands of hand sanitizers to happy customers around the world, an innocent post about the brand donating products sparked absolute outrage last week. The e-commerce store was soon shut down and banned by Facebook for "taking advantage of a crisis" after thousands flagged and reported the post for price gouging.

  • 0

LOS ANGELES, April 3, 2020 /PRNewswire/ -- In the wake of the current COVID-19 global health crisis, items like medical masks, disinfectants, and hand sanitizers have become scarce. But even after Z Skin Cosmetics had shipped thousands of hand sanitizers to happy customers around the world, an innocent post about the brand donating products sparked absolute outrage last week. The e-commerce store was soon shut down and banned by Facebook for "taking advantage of a crisis" after thousands flagged and reported the post for price gouging.

  • Updated
  • 0

In the midst of the coronavirus pandemic, millions of Americans suddenly found themselves jobless. Local food banks have stepped in to try and plug the food gap for their communities during this time of economic uncertainty.

  • Updated
  • 0

VISTA, Calif., April 3, 2020 /PRNewswire/ -- A maker of modular walls, McCain Manufacturing is now utilizing 100 percent of its manufacturing capabilities to quickly build and distribute COVID-19 containment spaces across the United States. The walls, which can be made with an antimicrobial coating, are being manufactured around the clock at the company's headquarters in Vista, California.

  • Updated
  • 0

VISTA, Calif., April 3, 2020 /PRNewswire/ -- A maker of modular walls, McCain Manufacturing is now utilizing 100 percent of its manufacturing capabilities to quickly build and distribute COVID-19 containment spaces across the United States. The walls, which can be made with an antimicrobial coating, are being manufactured around the clock at the company's headquarters in Vista, California.

  • Updated
  • 0

SACRAMENTO, Calif., April 3, 2020 /PRNewswire/ -- NorCal Services for Deaf & Hard of Hearing is being awarded by the federal Health Resources and Services Administration (HRSA-20-047) to support the current Newborn Hearing Screening Program (NHSP) with centralized services for families with infants who have been identified as deaf or hard of hearing. The NHSP is a state program that screens infants in hospitals for hearing loss and provide referrals to audiologists for further testing as needed. This $235,000 annual grant starting April 1st, 2020 for 4 years will allocate funding for the establishment of a statewide LEAD-K Family Services that includes Parent Mentor support (Parentlinks) and Individual Family Service Plan (IFSP) related services, specifically Deaf Coach services. Under the new grant, the program will continue to collaborate with the California Departments of Education (CDE), State Schools for the Deaf; Healthcare Services Coordination Centers, Hearing Coordination Centers; Social Services, Deaf Access Program; and Developmental Services, Regional Programs. Additional collaborators include the California Academy of Pediatrics, California Educators of the Deaf, Center for Early Intervention on Deafness, and CCHAT.

  • 0

SACRAMENTO, Calif., April 3, 2020 /PRNewswire/ -- NorCal Services for Deaf & Hard of Hearing is being awarded by the federal Health Resources and Services Administration (HRSA-20-047) to support the current Newborn Hearing Screening Program (NHSP) with centralized services for families with infants who have been identified as deaf or hard of hearing. The NHSP is a state program that screens infants in hospitals for hearing loss and provide referrals to audiologists for further testing as needed. This $235,000 annual grant starting April 1st, 2020 for 4 years will allocate funding for the establishment of a statewide LEAD-K Family Services that includes Parent Mentor support (Parentlinks) and Individual Family Service Plan (IFSP) related services, specifically Deaf Coach services. Under the new grant, the program will continue to collaborate with the California Departments of Education (CDE), State Schools for the Deaf; Healthcare Services Coordination Centers, Hearing Coordination Centers; Social Services, Deaf Access Program; and Developmental Services, Regional Programs. Additional collaborators include the California Academy of Pediatrics, California Educators of the Deaf, Center for Early Intervention on Deafness, and CCHAT.

  • Updated
  • 0

REDWOOD CITY, Calif., April 3, 2020 /PRNewswire/ -- Nevro Corp. ("Nevro") (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that the underwriter of each of Nevro's previously announced concurrent public offerings of (a) 1,625,000 shares of its common stock (the "common stock offering") and (b) $165,000,000 aggregate amount of its 2.75% convertible senior notes due 2025 (the "initial notes") (the "notes offering") has fully exercised its option to purchase an additional (a) 243,750 shares of Nevro's common stock at a public offering price of $84.00 per share, less underwriting discounts and commissions, and (b) an additional $24,750,000 aggregate amount of notes (the "additional notes" and, collectively with the initial notes, the "notes"), less underwriting discounts and commissions. Following the full exercise of the underwriter's option, Nevro anticipates selling an aggregate of 1,868,750 shares of its common stock, with total gross proceeds of approximately $157.0 million before deducting underwriting discounts and commissions and estimated offering expenses, and $189,750,000 aggregate amount of notes, before deducting underwriting discounts and commissions and estimated offering expenses. The offerings, including the common stock and additional notes that are part of the option exercise, are expected to close on April 6, 2020, subject to customary closing conditions.

  • Updated
  • 0

REDWOOD CITY, Calif., April 3, 2020 /PRNewswire/ -- Nevro Corp. ("Nevro") (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that the underwriter of each of Nevro's previously announced concurrent public offerings of (a) 1,625,000 shares of its common stock (the "common stock offering") and (b) $165,000,000 aggregate amount of its 2.75% convertible senior notes due 2025 (the "initial notes") (the "notes offering") has fully exercised its option to purchase an additional (a) 243,750 shares of Nevro's common stock at a public offering price of $84.00 per share, less underwriting discounts and commissions, and (b) an additional $24,750,000 aggregate amount of notes (the "additional notes" and, collectively with the initial notes, the "notes"), less underwriting discounts and commissions. Following the full exercise of the underwriter's option, Nevro anticipates selling an aggregate of 1,868,750 shares of its common stock, with total gross proceeds of approximately $157.0 million before deducting underwriting discounts and commissions and estimated offering expenses, and $189,750,000 aggregate amount of notes, before deducting underwriting discounts and commissions and estimated offering expenses. The offerings, including the common stock and additional notes that are part of the option exercise, are expected to close on April 6, 2020, subject to customary closing conditions.

  • Updated
  • 0

REDWOOD SHORES, Calif., April 3, 2020 /PRNewswire/ -- Oracle Corporation (NYSE:ORCL) today announced that it received notice of an unsolicited "mini-tender" offer by Ponos Industries LLC (Ponos Industries) to purchase up to 2,000,000 shares of Oracle capital stock, which represents approximately 0.063% of the common shares outstanding, at a price of $50.00 per share in cash.

  • Updated
  • 0

REDWOOD SHORES, Calif., April 3, 2020 /PRNewswire/ -- Oracle Corporation (NYSE:ORCL) today announced that it received notice of an unsolicited "mini-tender" offer by Ponos Industries LLC (Ponos Industries) to purchase up to 2,000,000 shares of Oracle capital stock, which represents approximately 0.063% of the common shares outstanding, at a price of $50.00 per share in cash.

  • Updated
  • 0

DALLAS and SAN DIEGO, April 3, 2020 /PRNewswire/ -- AMN Healthcare Services, Inc. (NYSE: AMN) today announced that, due to public health concerns relating to the novel coronavirus (COVID-19) pandemic, and to protect the health and well-being of its shareholders, directors and employees, AMN's 2020 Annual Meeting of Shareholders (the "Annual Meeting") will now be held virtually at 8:30 a.m. Central Time on April 22, 2020. The virtual meeting will provide shareholders the ability to participate, vote their shares, and ask questions during the meeting.

  • Updated
  • 0

DALLAS and SAN DIEGO, April 3, 2020 /PRNewswire/ -- AMN Healthcare Services, Inc. (NYSE: AMN) today announced that, due to public health concerns relating to the novel coronavirus (COVID-19) pandemic, and to protect the health and well-being of its shareholders, directors and employees, AMN's 2020 Annual Meeting of Shareholders (the "Annual Meeting") will now be held virtually at 8:30 a.m. Central Time on April 22, 2020. The virtual meeting will provide shareholders the ability to participate, vote their shares, and ask questions during the meeting.

  • Updated
  • 0

After CNN shared the story of Shujana Anthony, who was laid off from her job and unable to pay her rent, a viewer reached out and offered to pay Anthony's rent for her. CNN's Erin Burnett shares the news with Anthony live on air.

  • Updated
  • 0

R&B legend Bill Withers died on March 30th from heart complications at the age of 81. These are the memorable songs he left behind.

  • Updated
  • 0

BEIJING and SHANGHAI and SAN DIEGO, April 3, 2020 /PRNewswire/ -- Shenogen, a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients in China and beyond, today announced that it has entered into an exclusive collaboration and licensing agreement with Shanghai BioArdis Co., Ltd. and BioArdis LLC for the development and commercialization of BioArdis' novel FGFR4 (fibroblast growth factor receptor 4) kinase inhibitor, BIO-1262/SNG-203, either as monotherapy or combination therapy in Mainland China, Hong Kong, Macau and Taiwan. BioArdis will retain all rights to the licensed product in the rest of the world.

  • Updated
  • 0

BEIJING and SHANGHAI and SAN DIEGO, April 3, 2020 /PRNewswire/ -- Shenogen, a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients in China and beyond, today announced that it has entered into an exclusive collaboration and licensing agreement with Shanghai BioArdis Co., Ltd. and BioArdis LLC for the development and commercialization of BioArdis' novel FGFR4 (fibroblast growth factor receptor 4) kinase inhibitor, BIO-1262/SNG-203, either as monotherapy or combination therapy in Mainland China, Hong Kong, Macau and Taiwan. BioArdis will retain all rights to the licensed product in the rest of the world.

  • Updated
  • 0

FOUNTAIN VALLEY, Calif., April 3, 2020 /PRNewswire/ -- Hyundai Motor Company today launched a warranty extension policy for its vehicles worldwide, which includes America's Best Warranty for customers in the United States. The program aims to support Hyundai customers who may face difficulties in getting vehicles serviced and repaired during the COVID-19 pandemic.

  • Updated
  • 0

FOUNTAIN VALLEY, Calif., April 3, 2020 /PRNewswire/ -- Hyundai Motor Company today launched a warranty extension policy for its vehicles worldwide, which includes America's Best Warranty for customers in the United States. The program aims to support Hyundai customers who may face difficulties in getting vehicles serviced and repaired during the COVID-19 pandemic.

  • Updated
  • 0

MONTEREY, Calif., April 3, 2020 /PRNewswire/ -- U.S. broadcast station mergers and acquisitions (M&A) volume reached a total of $2.64 billion in the first quarter of 2020 as tracked by Kagan, the media research group within S&P Global Market Intelligence. 94.4% of this volume is attributable to Kagan's $2.49 billion estimate for the 64% buyout of Univision Holdings Inc.